Carisoprodol 500 mg (Pain O Soma)
$243.00 – $1,620.00
Carisoprodol 500 mg (Pain O Soma) | Variation | Price | Price / Unit | Quantity | Add To Cart |
---|---|---|---|---|
100 Tablet/s | $243.00 | $2.43/ Piece | ||
200 Tablet/s | $438.00 | $2.19/ Piece | ||
300 Tablet/s | $608.00 | $2.03/ Piece | ||
500 Tablet/s | $891.00 | $1.78/ Piece | ||
1000 Tablet/s | $1,620.00 | $1.62/ Piece |
Description
Carisoprodol is a muscle relaxant medication used to relieve discomfort associated with acute, painful musculoskeletal conditions. It works by affecting the communication between nerves in the central nervous system, resulting in muscle relaxation and pain relief. Carisoprodol is typically prescribed for short-term use, alongside rest, physical therapy, and other treatments, to manage conditions such as muscle spasms, strains, and sprains. However, it is important to use carisoprodol cautiously due to its potential for abuse and dependence.
Active Ingredient (Generic Name): | Carisoprodol |
Indication: | Muscle Relaxants |
Manufacturer: | HAB Pharma |
Packaging: | 10 Tablets in 1 Strip |
Strength: | 500 MG |
Delivery Time: | 6 To 15 days |
SKU: | Pain O Soma 500 mg |
Additional information
Quantity Value | 100 Tablet/s, 200 Tablet/s, 300 Tablet/s, 500 Tablet/s, 1000 Tablet/s |
---|
Be the first to review “Carisoprodol 500 mg (Pain O Soma)” Cancel reply
You must be logged in to post a review.
Related products
-
Carisoprodol 750 mg (Pain O Soma)
0 out of 5$270.00 – $1,800.00 Select options This product has multiple variants. The options may be chosen on the product page -
Gabapentin 600 mg
0 out of 5$270.00 – $1,800.00 Select options This product has multiple variants. The options may be chosen on the product page -
Gabapentin 800 mg
0 out of 5$300.00 – $2,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Pregabalin 75 mg
0 out of 5$197.00 – $1,313.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.